Epocal Raises $31 Million

Epocal Corp., an Ottawa-based developer of enterprise point-of-care blood diagnostic products, has raised US$31 million in Series C funding. Highland Capital Management led the deal, and was joined by return backer Genesys Capital Partners. Aquilo Partners served as placement agent. www.epocal.com